Atalanta Sosnoff Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-57,260
| Closed | -$29M | – | 104 |
|
|
2023
Q3 | $29M | Sell |
57,260
-58,694
| -51% | -$29.7M | 0.86% | 46 |
|
|
2023
Q2 | $60.5M | Sell |
115,954
-4,662
| -4% | -$2.43M | 1.64% | 17 |
|
|
2023
Q1 | $69.5M | Buy |
120,616
+59,311
| +97% | +$34.2M | 2.02% | 13 |
|
|
2022
Q4 | $33.8M | Buy |
+61,305
| New | +$33.8M | 1.04% | 39 |
|
|
2020
Q4 | – | Sell |
-15,223
| Closed | -$6.72M | – | 109 |
|
|
2020
Q3 | $6.72M | Sell |
15,223
-14,619
| -49% | -$6.45M | 0.19% | 72 |
|
|
2020
Q2 | $10.8M | Buy |
29,842
+14,117
| +90% | +$5.12M | 0.33% | 60 |
|
|
2020
Q1 | $4.46M | Buy |
15,725
+12,140
| +339% | +$3.44M | 0.16% | 70 |
|
|
2019
Q4 | $1.17M | Sell |
3,585
-5
| -0.1% | -$1.63K | 0.03% | 71 |
|
|
2019
Q3 | $1.05M | Hold |
3,590
| – | – | 0.03% | 68 |
|
|
2019
Q2 | $1.05M | Sell |
3,590
-1,645
| -31% | -$483K | 0.03% | 69 |
|
|
2019
Q1 | $1.43M | Buy |
5,235
+3,040
| +138% | +$832K | 0.04% | 64 |
|
|
2018
Q4 | $491K | Hold |
2,195
| – | – | 0.02% | 70 |
|
|
2018
Q3 | $536K | Buy |
+2,195
| New | +$536K | 0.02% | 64 |
|
|
2015
Q2 | – | Sell |
-296,760
| Closed | -$39.9M | – | 110 |
|
|
2015
Q1 | $39.9M | Sell |
296,760
-16,335
| -5% | -$2.19M | 1.06% | 45 |
|
|
2014
Q4 | $39.2M | Sell |
313,095
-14,288
| -4% | -$1.79M | 0.97% | 48 |
|
|
2014
Q3 | $39.8M | Buy |
+327,383
| New | +$39.8M | 0.99% | 44 |
|